Difference between revisions of "Yogaratnam"
m |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
= HBOT preconditioning prior to first time elective CABG improved intraoperative blood loss and reduced ICU stay. = | = HBOT preconditioning prior to first time elective CABG improved intraoperative blood loss and reduced ICU stay. = | ||
| + | |||
| + | <span style="font-size:large;">Clinical Bottom Line:</span> | ||
{| | {| | ||
|- | |- | ||
| | | | ||
| − | + | <span style="font-size:large;">1. Pre-treating elective CBP CABG patients with HBO resulted in reduced intra-operative blood loss and ICU stay.<br/> 2. Cardiac function post operatively may be improved and there may be improved cardioprotection from ischaemia- reperfusion injury</span> | |
|} | |} | ||
| − | + | <span style="font-size:medium;">'''Citations: '''1. Yogaratnam JZ, Laden G, Madden LA, Guvendik L, Cowen M, Greenman M, Seymour AM, Cale A, Griffin S. Hyperbaric oxygen preconditioning promotes cardioprotection following ischemic reperfusion injury by improving myocardial function, limiting necrosis and enhancing the induction of Hsp72. Undersea and Hyperbaric Medicine 2007; 34(4):301-302</span> | |
| − | <span style="font-size: | + | <span style="font-size:medium;">2. Yogaratnam J, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovascular Revascularization Medicine: Including Molecular Interventions 2010;11(1):8-19.</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">3. Jeysen ZY, Gerard L, Levant G, Cowen M, Cale A, Griffin S. Research report: the effects of hyperbaric oxygen preconditioning on myocardialbiomarkers of cardioprotection in patients having coronary artery bypass graft surgery. Undersea Hyperb Med. 2011 May-Jun;38(3):175-85 </span> |
| − | + | ---- | |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''Lead author's name and contact:''' Jeysen Yogaratnam jeysenzy@msn.com</span> |
| − | + | <span style="font-size:medium;">'''Three-part Clinical Question:'''For patients about to undergo on-pump coronary artery bypass grafting, does pre-operative HBOT improve outcomes?</span> | |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''Search Terms:''' Coronary artery bypass graft; cardiopulmonary bypass</span> |
| − | + | <span style="font-size:medium;">'''The Study: '''Single-blinded randomised controlled trial with intention-to-treat.</span> | |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''The Study Patients:''' First time elective CABG using CPB and with an ejection fraction >30%.</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''Control group''' (N = 40; 40 analysed): No specific intervention</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''Experimental group''' (N = 41; 41 analysed): On the day of surgery, 100% oxygen at 2.4ATA for 60 minutes 4 hours prior to procedure.</span> |
| − | + | <span style="font-size:medium;">'''The Evidence:'''</span> | |
| − | {| class="Table" style="width: | + | {| class="Table" style="width:558.0pt; border:solid windowtext 1.0pt" width="0" |
|- | |- | ||
| − | | | + | | style="border:solid windowtext 1.0pt" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Measure</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Measure</span></span>'''</span> | ||
| − | | colspan="2" style="width: | + | | colspan="2" style="width:95.25pt; border:solid windowtext 1.0pt" width="135" | <p align="center" style="text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Control Group</span></span>'''</span></p> |
| − | | colspan="2" style="width: | + | | colspan="2" style="width:81.0pt; border:solid windowtext 1.0pt" width="125" | <p align="center" style="text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">HBO Group</span></span>'''</span></p> |
| − | | style="width: | + | | style="width:72.75pt; border:solid windowtext 1.0pt" width="99" | <p align="center" style="text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Difference</span></span>'''</span></p> |
| − | | style="width: | + | | style="width:67.5pt; border:solid windowtext 1.0pt" width="93" | <p align="center" style="text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">95% CI</span></span>'''</span></p> |
|- | |- | ||
| − | | rowspan="2" | | + | | rowspan="2" style="border:solid windowtext 1.0pt" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Stroke Volume 24 hours postop. (mls)</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Stroke Volume 24 hours postop. (mls)</span></span>'''</span> | ||
| − | | <p style="margin-bottom: | + | | style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Mean</span></span>'''</span></p> |
| − | | style="width: | + | | style="width:48.0pt; border:solid windowtext 1.0pt" width="77" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">SD</span></span>'''</span></p> |
| − | | style="width: | + | | style="width:20.25pt; border:solid windowtext 1.0pt" width="44" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Mean</span></span>'''</span></p> |
| − | | style="width: | + | | style="width:56.25pt; border:solid windowtext 1.0pt" width="81" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">SD</span></span>'''</span></p> |
| − | | style=" | + | | style="width:72.75pt; border:solid windowtext 1.0pt; padding:.75pt .75pt .75pt .75pt" width="99" | |
| − | | style=" | + | | style="width:67.5pt; border:solid windowtext 1.0pt; padding:.75pt .75pt .75pt .75pt" width="93" | |
|- | |- | ||
| − | | <p style="margin-bottom: | + | | style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">63.1</span></span></span></p> |
| − | | style="width: | + | | style="width:48.0pt; border:solid windowtext 1.0pt" width="77" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">13.9</span></span></span></p> |
| − | | style="width: | + | | style="width:20.25pt; border:solid windowtext 1.0pt" width="44" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">74.6</span></span></span></p> |
| − | | style="width: | + | | style="width:56.25pt; border:solid windowtext 1.0pt" width="81" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">19.7</span></span></span></p> |
| − | | style="width: | + | | style="width:72.75pt; border:solid windowtext 1.0pt" width="99" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">11.5</span></span></span></p> |
| − | | style="width: | + | | style="width:67.5pt; border:solid windowtext 1.0pt" width="93" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">-156 to 179</span></span></span></p> |
|} | |} | ||
| | ||
| − | {| class="Table" style="width: | + | {| class="Table" style="width:561.75pt; border:solid windowtext 1.0pt" width="0" |
|- | |- | ||
| − | | | + | | style="border:solid windowtext 1.0pt" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Non-Event Outcomes</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Non-Event Outcomes</span></span>'''</span> | ||
| − | | style="width: | + | | style="width:122.25pt; border:solid windowtext 1.0pt" width="165" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Control group mean</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Control group mean</span></span>'''</span> | ||
| − | | style="width: | + | | style="width:153.0pt; border:solid windowtext 1.0pt" width="206" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Experimental group mean</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Experimental group mean</span></span>'''</span> | ||
| − | | style="width: | + | | style="width:48.75pt; border:solid windowtext 1.0pt" width="68" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">P-value</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">P-value</span></span>'''</span> | ||
|- | |- | ||
| − | | | + | | style="border:solid windowtext 1.0pt" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">ICU stay in hours</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">ICU stay in hours</span></span>'''</span> | ||
| − | | style="width: | + | | style="width:122.25pt; border:solid windowtext 1.0pt" width="165" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">1051</span></span></span></p> |
| − | | style="width: | + | | style="width:153.0pt; border:solid windowtext 1.0pt" width="206" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">850</span></span></span></p> |
| − | | style="width: | + | | style="width:48.75pt; border:solid windowtext 1.0pt" width="68" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">0.05</span></span></span></p> |
|- | |- | ||
| − | | | + | | style="border:solid windowtext 1.0pt" | |
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Intraoperative blood loss (mean in ml)</span></span>'''</span> | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Intraoperative blood loss (mean in ml)</span></span>'''</span> | ||
| − | | style="width: | + | | style="width:122.25pt; border:solid windowtext 1.0pt" width="165" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">309</span></span></span></p> |
| − | | style="width: | + | | style="width:153.0pt; border:solid windowtext 1.0pt" width="206" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">133</span></span></span></p> |
| − | | style="width: | + | | style="width:48.75pt; border:solid windowtext 1.0pt" width="68" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">0.02</span></span></span></p> |
|} | |} | ||
| | ||
| − | + | <span style="font-size:medium;">'''Comments:'''</span> | |
| − | <span style="font-size: | + | <span style="font-size:medium;">1. Other findings were not statistically significant but tended towards a more favourable outcome in the HBO group.</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">2. Only 25 control and 22 intervention patients (58%) had haemodynamic studies due to lack of equipment. Bias may have been towards monitoring the more unwell patients in each group.</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">3. The exclusion criteria removed the most at risk patients, so these results apply to low risk patients.</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">4. Cost analysis conducted by the study found a saving of US $582.5 per HBOT patient in the intervention group based on a comparison of ICU bed cost and HBOT cost.</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">5. Third citation documented lower levels of eNOS and heat shock protein 72 (HSP72) within myocardial cells after induction and during CPB, but an increase after the period of ischaemia, This may imply an increase in endogenous myocardial protection.</span> |
| − | + | <span style="font-size:medium;">'''Appraised by:'''Nicholas Titheridge HMAS PENGUIN, SUMU-E; Monday, 4 June 2018. Third citation by M Bennett May 2019.</span> | |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''Email:''' ntitheridge@gmail.com</span> |
| − | <span style="font-size: | + | <span style="font-size:medium;">'''Kill or Update By:''' June 2024</span> |
| | ||
| Line 117: | Line 119: | ||
[[File:Sumhorsa.gif|center|Sumhorsa.gif]] | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | ||
| − | <span style="color: #7c00ff; display: block; font-size: 26px; text-align: center;">'''[[ | + | <span style="color: #7c00ff; display: block; font-size: 26px; text-align: center;">'''[[Myocardial_ischaemia|BACK]]'''</span> |
Latest revision as of 04:03, 22 August 2022
HBOT preconditioning prior to first time elective CABG improved intraoperative blood loss and reduced ICU stay.
Clinical Bottom Line:
|
1. Pre-treating elective CBP CABG patients with HBO resulted in reduced intra-operative blood loss and ICU stay. |
Citations: 1. Yogaratnam JZ, Laden G, Madden LA, Guvendik L, Cowen M, Greenman M, Seymour AM, Cale A, Griffin S. Hyperbaric oxygen preconditioning promotes cardioprotection following ischemic reperfusion injury by improving myocardial function, limiting necrosis and enhancing the induction of Hsp72. Undersea and Hyperbaric Medicine 2007; 34(4):301-302
2. Yogaratnam J, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovascular Revascularization Medicine: Including Molecular Interventions 2010;11(1):8-19.
3. Jeysen ZY, Gerard L, Levant G, Cowen M, Cale A, Griffin S. Research report: the effects of hyperbaric oxygen preconditioning on myocardialbiomarkers of cardioprotection in patients having coronary artery bypass graft surgery. Undersea Hyperb Med. 2011 May-Jun;38(3):175-85
Lead author's name and contact: Jeysen Yogaratnam jeysenzy@msn.com
Three-part Clinical Question:For patients about to undergo on-pump coronary artery bypass grafting, does pre-operative HBOT improve outcomes?
Search Terms: Coronary artery bypass graft; cardiopulmonary bypass
The Study: Single-blinded randomised controlled trial with intention-to-treat.
The Study Patients: First time elective CABG using CPB and with an ejection fraction >30%.
Control group (N = 40; 40 analysed): No specific intervention
Experimental group (N = 41; 41 analysed): On the day of surgery, 100% oxygen at 2.4ATA for 60 minutes 4 hours prior to procedure.
The Evidence:
|
Measure |
Control Group |
HBO Group |
Difference |
95% CI | ||
|
Stroke Volume 24 hours postop. (mls) |
Mean |
SD |
Mean |
SD |
||
63.1 |
13.9 |
74.6 |
19.7 |
11.5 |
-156 to 179 | |
|
Non-Event Outcomes |
Control group mean |
Experimental group mean |
P-value |
|
ICU stay in hours |
1051 |
850 |
0.05 |
|
Intraoperative blood loss (mean in ml) |
309 |
133 |
0.02 |
Comments:
1. Other findings were not statistically significant but tended towards a more favourable outcome in the HBO group.
2. Only 25 control and 22 intervention patients (58%) had haemodynamic studies due to lack of equipment. Bias may have been towards monitoring the more unwell patients in each group.
3. The exclusion criteria removed the most at risk patients, so these results apply to low risk patients.
4. Cost analysis conducted by the study found a saving of US $582.5 per HBOT patient in the intervention group based on a comparison of ICU bed cost and HBOT cost.
5. Third citation documented lower levels of eNOS and heat shock protein 72 (HSP72) within myocardial cells after induction and during CPB, but an increase after the period of ischaemia, This may imply an increase in endogenous myocardial protection.
Appraised by:Nicholas Titheridge HMAS PENGUIN, SUMU-E; Monday, 4 June 2018. Third citation by M Bennett May 2019.
Email: ntitheridge@gmail.com
Kill or Update By: June 2024